PROGNOSTIC VALUE OF HOST IMMUNOCOMPETENCE IN UROLOGIC CANCER-PATIENTS

被引：33

作者：

CATALONA, WJ ^{[1
]}

SMOLEV, JK ^{[1
]}

HARTY, JI ^{[1
]}

机构：

[1] JOHNS HOPKINS HOSP,JAMES BUCHANAN BRADY UROL INST,BALTIMORE,MD 21205

来源：

关键词：

D O I：

10.1016/S0022-5347(17)67175-1

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：922 / 926

页数：5

共 18 条

[1] ALEXANDER P, 1973, C USE BCG THERAPY CA, P267
[2] BRANNEN GE, 1975, CANCER CHEMOTH REP 1, V59, P127
[3] CATALONA WJ, 1972, CLIN EXP IMMUNOL, V12, P325
[4] EFFECTS OF CHEMOTHERAPY FOR PROSTATIC CARCINOMA ON T LYMPHOCYTE LEVELS
CATALONA, WJ
[J]. JOURNAL OF UROLOGY, 1974, 112 (06) : 802 - 807
[5] CORRELATION AMONG HOST IMMUNOCOMPETENCE AND TUMOR STAGE, TUMOR GRADE AND VASCULAR PERMEATION IN TRANSITIONAL CARCINOMA
CATALONA, WJ
CHRETIEN, PB
[J]. JOURNAL OF UROLOGY, 1973, 110 (05) : 526 - 528
[6] ABNORMALITIES OF CELL-MEDIATED IMMUNOCOMPETENCE IN GENITOURINARY CANCER
CATALONA, WJ
CHRETIEN, PB
TRAHAN, EE
[J]. JOURNAL OF UROLOGY, 1974, 111 (02) : 229 - 232
[7] CHAKRAVORTY RC, 1973, SURGERY, V73, P730
[8] Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO
[9] 2-V
[10] GOOD RA, 1970, IMMUNE SURVEILLANCE, P443